Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

7.14
+0.22003.18%
Volume:488.95K
Turnover:3.49M
Market Cap:138.10M
PE:-1.17
High:7.47
Open:6.86
Low:6.82
Close:6.92
52wk High:20.56
52wk Low:6.33
Shares:19.34M
Float Shares:17.42M
Volume Ratio:0.83
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.35
PE(LYR):-1.21

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst

TIPRANKS
·
Aug 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 19

Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.0%, Outperforms Peers

Dow Jones
·
Aug 18

Corbus Grants CMO Inducement Awards Including Option for 191,676 Shares at $10.09 Exercise Price

Reuters
·
Aug 17

Corbus Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 17

Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 17

Corbus Pharmaceuticals price target lowered to $33 from $34 at Mizuho

TIPRANKS
·
Aug 17

Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating

MT Newswires Live
·
Aug 13

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 13

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Aug 13

Corbus Chief Business Officer Nishant Saxena Acquires 2,600 Shares Worth $25,037.44

Reuters
·
Aug 13

RBC Capital Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Aug 12